LXEO Institutional Ownership & Shareholders

LEXEO THERAPEUTICS INC (LXEO) is currently held by 143 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $417.22M based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.

Suvretta Capital Management, Llc is currently the largest disclosed institutional shareholder of LXEO tracked by InsiderSet, reporting ownership valued at approximately $29.72M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $19.54M, representing an estimated loss of -34.26% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 57% of the total disclosed LXEO value among the investors covered in this analysis. Major shareholders include Suvretta Capital Management, Llc, Janus Henderson Group Plc, Affinity Asset Advisors, Llc, and several other long-term asset managers with concentrated positions in LEXEO THERAPEUTICS INC (LXEO).

This page ranks the largest institutional LXEO shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

143

Total Reported Value

$417.22M

Largest Holder

Suvretta Capital Management, Llc

Largest Position

$29.72M

Insider Transactions (90d)

6

Latest Filing Quarter

Q2 2026

New Institutional Positions

88

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Suvretta Capital Management, Llc0.62%6,384,200$29,718,451$19,535,652-$10,182,799-34.26%
Janus Henderson Group Plc0.01%4,976,429$28,510,358$15,227,873-$13,282,485-46.59%
Affinity Asset Advisors, Llc1.32%5,807,611$27,034,429$17,771,290-$9,263,139-34.26%
Blackrock, Inc.0.00%5,739,455$26,717,165$17,562,732-$9,154,433-34.26%
Ra Capital Management, L.P.0.20%5,000,000$23,275,000$15,300,000-$7,975,000-34.26%
Frazier Life Sciences Management, L.P.0.49%4,824,725$22,459,095$14,763,659-$7,695,437-34.26%
State Street Corp0.00%4,354,757$20,271,394$13,325,556-$6,945,838-34.26%
Vestal Point Capital, Lp0.47%4,320,000$20,109,600$13,219,200-$6,890,400-34.26%
Paradigm Biocapital Advisors Lp0.36%4,175,382$19,436,403$12,776,669-$6,659,734-34.26%
Orbimed Advisors Llc0.35%3,947,850$18,377,242$12,080,421-$6,296,821-34.26%
Citadel Advisors Llc0.01%3,898,570$18,147,843$11,929,624-$6,218,219-34.26%
Vanguard Capital Management Llc0.00%3,125,893$14,551,032$9,565,233-$4,985,799-34.26%
Millennium Management Llc0.01%2,833,622$13,190,510$8,670,883-$4,519,627-34.26%
Woodline Partners Lp0.04%2,500,532$11,639,976$7,651,628-$3,988,348-34.26%
Balyasny Asset Management L.P.0.02%2,412,742$11,231,314$7,382,991-$3,848,323-34.26%
Goldman Sachs Group Inc0.00%2,149,612$10,006,444$6,577,813-$3,428,631-34.26%
683 Capital Management, Llc0.80%1,875,000$8,728,124$5,737,500-$2,990,624-34.26%
Geode Capital Management, Llc0.00%1,747,959$8,138,547$5,348,755-$2,789,792-34.28%
Adar1 Capital Management, Llc0.34%1,565,950$7,289,497$4,791,807-$2,497,690-34.26%
Avoro Capital Advisors Llc0.06%1,489,189$6,932,175$4,556,918-$2,375,257-34.26%
Qube Research & Technologies Ltd0.01%1,376,222$6,406,313$4,211,239-$2,195,074-34.26%
Nantahala Capital Management, Llc0.37%1,300,000$6,051,500$3,978,000-$2,073,500-34.26%
Dimensional Fund Advisors Lp0.00%1,287,185$5,992,745$3,938,786-$2,053,959-34.27%
Spruce Street Capital Lp0.85%928,593$4,322,600$2,841,495-$1,481,105-34.26%
Northern Trust Corp0.00%867,391$4,037,705$2,654,216-$1,383,489-34.26%
Aberdeen Group Plc0.00%675,092$3,142,553$2,065,782-$1,076,771-34.26%
Vanguard Portfolio Management Llc0.00%613,826$2,857,360$1,878,308-$979,052-34.26%
Ikarian Capital, Llc0.39%513,011$2,388,066$1,569,814-$818,252-34.26%
Bank Of America Corp0.00%490,331$2,282,490$1,500,413-$782,077-34.26%
Vanguard Fiduciary Trust Co0.00%430,696$2,004,890$1,317,930-$686,960-34.26%
Morgan Stanley0.00%395,102$1,839,200$1,209,012-$630,188-34.26%
Bnp Paribas Financial Markets0.00%388,398$1,807,993$1,188,498-$619,495-34.26%
Dafna Capital Management Llc0.33%377,059$1,755,210$1,153,801-$601,409-34.26%
Ubs Group Ag0.00%354,044$1,648,074$1,083,375-$564,699-34.26%
Trexquant Investment Lp0.01%314,891$1,465,818$963,566-$502,252-34.26%
Squarepoint Ops Llc0.00%294,774$1,372,173$902,008-$470,165-34.26%
Hennion & Walsh Asset Management, Inc.0.04%381,989$1,291,123$1,168,886-$122,237-9.47%
Aqr Capital Management Llc0.00%256,661$1,194,757$785,383-$409,374-34.26%
Renaissance Technologies LLCJim Simons0.00%250,365$1,165,449$766,117-$399,332-34.26%
Wellington Management Group Llp0.00%202,383$942,093$619,292-$322,801-34.26%
Nuveen, Llc0.00%200,417$932,941$613,276-$319,665-34.26%
Bank Of New York Mellon Corp0.00%183,883$855,975$562,682-$293,293-34.26%
Charles Schwab Investment Management Inc0.00%172,609$803,495$528,184-$275,311-34.26%
Susquehanna Portfolio Strategies, Llc0.01%161,062$749,744$492,850-$256,894-34.26%
Xtx Topco Ltd0.01%145,556$677,563$445,401-$232,162-34.26%
Fmr Llc0.00%141,146$657,035$431,907-$225,128-34.26%
Boothbay Fund Management, Llc0.01%136,377$634,835$417,314-$217,521-34.26%
Creative Planning0.00%177,252$599,112$542,391-$56,721-9.47%
Burkehill Global Management, Lp0.02%125,000$581,875$382,500-$199,375-34.26%
Raymond James Financial Inc0.00%117,388$546,441$359,207-$187,234-34.26%
Showing 50 of 143

Frequently asked questions about LXEO

  • Who are the largest institutional holders of LXEO?

    The largest institutional holders of LXEO reported in the latest SEC Form 13F filings include Suvretta Capital Management, Llc, Janus Henderson Group Plc, Affinity Asset Advisors, Llc, Blackrock, Inc., and Ra Capital Management, L.P.. InsiderSet ranks institutional holders by their latest reported LXEO position.

  • What is LXEO institutional ownership?

    This page tracks LXEO positions reported by institutional investment managers through SEC Form 13F. LEXEO THERAPEUTICS INC (LXEO) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.

  • How many institutions own LXEO?

    InsiderSet currently tracks 143 institutional managers reporting LXEO holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of LXEO shareholders.

  • How much LXEO stock do institutions own?

    Institutional investment managers disclosed approximately $417.22M in LXEO holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.

  • When was LXEO institutional ownership last updated?

    The latest LXEO institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.

  • Are institutional LXEO holdings real-time?

    No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its LXEO position after the reporting date.

  • Are institutions buying or selling LXEO?

    Institutional buying and selling can be analyzed by comparing LXEO positions across consecutive 13F reporting periods. InsiderSet's LXEO Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View LXEO ownership changes.

  • How has LXEO institutional ownership changed over time?

    InsiderSet tracks LXEO institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.